Author

Spyridon Vrakas 1

1 Tzaneion General Hospital of Piraeus,Piraeus,Greece

ASSOCIATION OF COLORECTAL CANCERS AND SYNCHRONOUS POLYPS IN A PERIOD OF 15 YEARS: CHANGING PATTERN?

Spyridon Vrakas

ASSOCIATION OF COLORECTAL CANCERS AND SYNCHRONOUS POLYPS IN A PERIOD OF 15 YEARS: CHANGING PATTERN?

Spyridon Vrakas, Georgios Michalopoulos, Vassiliki Ntouli, Konstantinos Makris, Christina Kapizioni, Konstantina Milioni, GEORGIOS KOUTOUFARIS, Panagiotis Kourkoulis, Panagiotis Giannelis, Vassileios Xourgias

Compliance with international guidelines on vaccination and malignancy prevention among patients with inflammatory bowel disease

Aristotelis Mellos, Georgios Michalopoulos, Konstantinos Makris, Christina Kapizioni, Panagiotis Kourkoulis, GEORGIOS KOUTOUFARIS, Konstantia Milioni, Panagiotis Giannelis, Spyridon Vrakas, Vasileios Xourgias

INTESTINAL TOTAL BACTERIA CONCENTRATION AND TRANSLOCATION OF BACTERIA AT THE INFLAMMATORY BOWEL DISEASE

Spyridon Vrakas, Maria Gazouli, Konstantinos Mountzouris, Georgios Michalopoulos, George P. Karamanolis, Georgios Papatheodoridis, Charalampos Tzathas

NEED FOR USTEKINUMAB INTENSIFICATION IN REAL LIFE CLINICAL PRACTICE

Triantafillos Argirakis, Charalampos Thanos, Theodoros Alexopoulos, Spyridon Vrakas, Georgios Michalopoulos, Pantelis Karatzas, Vasileios Ntelis, Georgios Papatheodoridis, Vasileios Xourgias

NEED FOR USTEKINUMAB INTENSIFICATION IN REAL LIFE CLINICAL PRACTICE

Spyridon Vrakas

NEED FOR VEDOLIZUMAB INTENSIFICATION IN REAL LIFE CLINICAL PRACTICE

Spyridon Vrakas

NEED FOR VEDOLIZUMAB INTENSIFICATION IN REAL LIFE CLINICAL PRACTICE

Theodoros Alexopoulos, EVANGELOS IONAS, Sofia Kartsoli, Pantelis Karatzas, Georgios Michalopoulos, Spyridon Vrakas, Vasilios Delis, Vasileios Xourgias, Georgios Papatheodoridis

PATIENTS PERSPECTIVE ON SWITCHING FROM INTRAVENOUS TO SUCUTANEOUS THERAPY

Evmorfia Karamintziou, Theodoros Alexopoulos, Marilena Tooulia, Georgios Michalopoulos, Pantelis Karatzas, Spyridon Vrakas, Georgios Papatheodoridis, Vasileios Xourgias, Vasileios Ntelis

PATIENTS PERSPECTIVE ON SWITCHING FROM INTRAVENOUS TO SUCUTANEOUS THERAPY

Spyridon Vrakas

Item 1 - 10 / 14
1
2